ALK, a research-driven pharmaceutical company, has entered into a supply contract with HealthTrust Purchasing Group for PRE-PEN (benzylpenicilloyl polylysine injection USP). HealthTrust will include the PRE-PEN skin test, used for the ...
Tags: ALK, HealthTrust, PRE-PEN skin test
Hospira has entered into a definitive agreement to purchase Orchid Chemicals&Pharmaceuticals'FDA-approved active pharmaceutical ingredient(API)manufacturing and Chennai-based R&D facilities for approximately$200m. The acquisition will ...
Tags: Orchid Chemicals, Hospira, active pharmaceutical ingredient
The US Food and Drug Administration(FDA)has granted orphan drug designation to Savara Pharmaceuticals'first inhaled antibiotic,designed for the treatment of pulmonary methicillin-resistant Staphylococcus aureus(MRSA)infection in cystic ...
Tags: Orphan Drug, Savara Pharma, FDA, inhaled antibiotic, MRSA
Basilea Pharmaceutica has commenced next pharmacokinetic Phase 1 study with antibiotic BAL30072 in healthy volunteers. The injectable sulfactam antibiotic has the potential to target clinically relevant gram-negative bacteria resistant to ...
Galapagos has identified new class of antibiotics targeting drug resistant Staphylococcus aureus (MRSA) strains and commenced clinical development of first antibiotic. The selected candidate, CAM-1, was effective against all tested MRSA ...
Tags: antibiotics targeting drug, MRSA
The US Food and Drug Administration's (FDA) Center For Drug Evaluation and Research has issued new guidelines for the packaging of test batches manufactured for Abbreviated New Drug Applications (ANDA), Abbreviated Antibiotic Applications ...
Tags: FDA, food, drug, packaging, test batches, ANDA, labeling
SIRS-Lab has completed enrolling patients in a clinical study of its VYOO molecular diagnostic test, designed to detect presence of pathogens' genetic material from whole blood. The prospective, blinded multicenter study, which has ...
Tags: VYOO molecular diagnostic test, pathogens'genetic material, VYOO test